Anticoagulants in patients with atrial fibrillation and end-stage renal disease.


Atrial fibrillation (AF) is a common cardiac arrhythmia and is associated with an increased risk for thromboembolic stroke. Anticoagulant therapy has been shown to reduce the risk for ischemic stroke in patients with AF; however, these studies have excluded patients with end-stage renal disease (ESRD). This review examines the relationships between ESRD, AF… (More)
DOI: 10.3810/pgm.2012.11.2609


  • Blog articles referencing this paper

  • Presentations referencing similar topics